Dermal Allograft Innovation Grants
Forecasted
Dermal Allograft Innovation Grants from the Musculoskeletal Transplant Foundation support cutting-edge research on new technologies and clinical uses for allograft dermal matrices and skin in regenerative medicine.
Funder: Musculoskeletal Transplant Foundation
Due Dates (Anticipated): March 2027 (Letter of Intent) | June 2027 (Full application)
Funding Amounts: Up to $250,000 over 3 years (Established Investigator or Career Development) or $75,000 over 1 year (Junior Investigator); indirect costs capped at 20%.
Summary: Supports innovative translational and clinical research advancing new technologies and clinical applications for allograft dermal matrices and skin in regenerative and reconstructive medicine.
Key Information: This is a forecasted grant; all deadlines are projected—refer to the program page for updates.
Description
The Dermal Allograft Innovation Grants, offered by the Musculoskeletal Transplant Foundation (MTF Biologics), fund pioneering research to advance the science and clinical use of allograft dermal matrices (ADM) and skin allografts. The program aims to foster innovation in regenerative and reconstructive medicine by supporting projects that develop new enabling technologies, novel clinical uses, advanced preservation or delivery methods, and next-generation product forms. Areas of interest include, but are not limited to, flowable or particulate ADM, 3D-printed constructs, tissue-engineered skin, viable dermal tissues, and improved storage or handling solutions. Both translational and clinical research proposals are welcomed, provided they demonstrate clear potential for clinical translation and impact on patient care.
